Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review

BACKGROUND: Despite more than 60 years of clinical trials, tuberculosis (TB) still causes a high global burden of mortality and morbidity. Treatment currently requires multiple drugs in combination, taken over a prolonged period. New drugs are needed to shorten treatment duration, prevent resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnett, Laura Jayne, Ken-Dror, Gie, Davies, Geraint Rhys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822642/
https://www.ncbi.nlm.nih.gov/pubmed/29467027
http://dx.doi.org/10.1186/s13063-018-2522-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822642/
https://www.ncbi.nlm.nih.gov/pubmed/29467027
http://dx.doi.org/10.1186/s13063-018-2522-x

Ejemplares similares